FACTORS INFLUENCING RELEASE OF DRUG FROM PROLONGED-ACTION MATRIX

[1] HIGUCHI T, 1964, J PHARM SCI, V53, P532

[2] ABSORPTION, TESTING, AND CLINICAL EVALUATION OF ORAL PROLONGED-ACTION DRUGS [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1961, 50 (09) : 715 - +

[3] ORAL PROLONGED ACTION MEDICAMENTS - THEIR PHARMACEUTICAL CONTROL AND THERAPEUTIC ASPECTS [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1959, 11 (05) : 257 - 290

[4] MUNZEL K, 1960, ARCH PHARM, V65, P766

[5] NELSON E, 1961, REMINGTONS PRACTICE, pCH38

[6] SIMOONS JRA, 1962, FORMULATION EXPERIME

[7] SJOGREN JOHN, 1960, FARM REVY, V59, P171

[8] Wagner JG, 1959, DRUG STAND, V27, P178

[9] WIEGAND RG, 1959, DRUG STDS, V27, P166

[1] HIGUCHI T, 1964, J PHARM SCI, V53, P532

[2] ABSORPTION, TESTING, AND CLINICAL EVALUATION OF ORAL PROLONGED-ACTION DRUGS [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1961, 50 (09) : 715 - +

[3] ORAL PROLONGED ACTION MEDICAMENTS - THEIR PHARMACEUTICAL CONTROL AND THERAPEUTIC ASPECTS [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1959, 11 (05) : 257 - 290

[4] MUNZEL K, 1960, ARCH PHARM, V65, P766

[5] NELSON E, 1961, REMINGTONS PRACTICE, pCH38

[6] SIMOONS JRA, 1962, FORMULATION EXPERIME

[7] SJOGREN JOHN, 1960, FARM REVY, V59, P171

[8] Wagner JG, 1959, DRUG STAND, V27, P178

[9] WIEGAND RG, 1959, DRUG STDS, V27, P166